Correlation Between Design Therapeutics and 126408GW7

Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and 126408GW7 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and 126408GW7 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Design Therapeutics and CSX P 475, you can compare the effects of market volatilities on Design Therapeutics and 126408GW7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of 126408GW7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and 126408GW7.

Diversification Opportunities for Design Therapeutics and 126408GW7

-0.7

Correlation Coefficient

Design Therapeutics  126408GW7

Excellent diversification

The 3 months correlation between Design and 126408GW7 is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and CSX P 475 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSX P 475 and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with 126408GW7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSX P 475 has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and 126408GW7 go up and down completely randomly.

Pair Corralation between Design Therapeutics and 126408GW7

Given the investment horizon of 90 days Design Therapeutics is expected to generate 5.15 times more return on investment than 126408GW7. However, Design Therapeutics is 5.15 times more volatile than CSX P 475. It trades about 0.1 of its potential returns per unit of risk. CSX P 475 is currently generating about -0.07 per unit of risk. If you would invest  467.00  in Design Therapeutics on October 10, 2024 and sell it today you would earn a total of  125.00  from holding Design Therapeutics or generate 26.77% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	77.05%
Values	Daily Returns

Design Therapeutics  vs.  CSX P 475

Design Therapeutics

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Design Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Design Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

CSX P 475

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CSX P 475 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 126408GW7 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Design Therapeutics and 126408GW7

The main advantage of trading using opposite Design Therapeutics and 126408GW7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, 126408GW7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 126408GW7 will offset losses from the drop in 126408GW7's long position.

The idea behind Design Therapeutics and CSX P 475 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.